Intelligyn's Commitment to Gynecological Care
Intelligyn is a spin-out of Karolinska Institutet and The Royal Institute of Technology (KTH) in Stockholm, Sweden, with the mission to drastically improve ovarian cancer diagnostics by bringing cutting-edge AI research into clinical use. Our research create solutions that prioritizes patient care and streamlines the efficiency of healthcare systems.
Publications
-
Proof of Concept Study
To develop and test the performance of computerized ultrasound image analysis using deep neural networks (DNNs) in discriminating between benign and malignant ovarian tumors and to compare its diagnostic accuracy with that of subjective assessment (SA) by an ultrasound expert.
-
Educational Platform Study
This study has scientifically proven to improve a clinician’s ability to characterise lesions as benign or malignant with greater specificity from 70% to 89% when used for a minimum of 200 cases or about 5 hours of use.